Digital The optimal mix of AI and human interactions for healthcare ... Pharmaceutical firms all around the world are investing in AI technology alongside human experts to help provide satisfying HCP engagement experiences
R&D Is biotech ready for the lecanemab opportunity? The US Veterans Health Administration recently announced that it will cover the cost of Biogen’s lecanemab for veterans suffering from early stages of Alzheimer’s disease.
Digital When will “digital health” just become health? Despite the significant drop in funding in 2022, digital health is here to stay.
R&D BioGPT: A game-changer for pharma and healthcare ChatGPT has already made waves and has been deployed to write codes, new poems, songs, recipes, and whatnot.
Digital The digital skills pharma leaders need in 2023 Pharma companies are needing to look at cost-effective ways to stay ahead of the competition.
Digital The power of a carer's intuition - AI in social care Data and AI allow carers to better understand which patients are at risk and intervene earlier.
News Relief for AZ as Truqap hits the spot in prostate cancer After a disappointing result with Truqap in triple-negative breast cancer, AstraZeneca chalks up a win in prostate cancer
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends